12 results
SC 14D9
EX-99
SGTX
Sigilon Therapeutics Inc
13 Jul 23
Tender offer solicitation
8:18am
certified public accountant or by an appraiser or other expert selected with reasonable care by the Enterprise. In addition, the knowledge and/or actions
DEF 14A
SGTX
Sigilon Therapeutics Inc
27 Apr 21
Definitive proxy
4:49pm
committee financial expert” within the meaning of the Securities and Exchange Commission, or SEC, regulations and applicable listing standards of Nasdaq … . Shaff) is an Audit Committee financial expert as defined by the rules of the SEC.
The Audit Committee met three times during fiscal 2020 with Sigilon
8-K
EX-3.2
SGTX
Sigilon Therapeutics Inc
8 Dec 20
Amendments to Articles of Incorporation or Bylaws
5:05pm
are within such other person’s or entity’s professional or expert competence and that has been selected with reasonable care by or on behalf
424B4
jscfcjzrkmay9y5d
7 Dec 20
Prospectus supplement with pricing info
9:10am
S-1/A
m4ay4
30 Nov 20
IPO registration (amended)
6:41am
S-1/A
EX-3.5
1vsq3hmh 7rd5e
30 Nov 20
IPO registration (amended)
6:41am
S-1
cvn4uf4gnib
13 Nov 20
IPO registration
3:27pm
DRS/A
s26j1jmsaqoti
30 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
aqkamuly se8ht1x
28 Sep 20
Draft registration statement (amended)
12:00am
DRS
b4y6bmr 3q
21 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next